comprehensive -WSS

comprehensive

author：knowledge 2025-09-27 10:02:40 - browse：44

The human gut teems with bacteria and other colorful microbes. — NIH

One of the indignities of getting older is the way your body’s defenses against microbes begin to break down, leaving you extra vulnerable to infection. Researchers studying the ways these systems change with age refer to them collectively as “immunosenescence,” or, more poetically, the “twilight of immunity.” But even as scientific understanding of the phenomenon has grown over the past decade, the forces driving it remain murky.

One theory is that it all starts in the bone marrow, where a primitive reserve of stem cells replenishes the ranks of blood and immune cells to the tune of about 500 billion new cells every day. Some of these hematopoietic stem cells, or HSCs, are more likely to become long-lived stewards of immune memory like B cells and T cells; others are more likely to give rise to blood cells and front-line immune defenders. They all work in concert to get the balance right. As people age, though, one lineage of HSCs starts to dominate, throwing the equilibrium off-kilter.

On Wednesday, a team of scientists at Stanford University and the National Institutes of Health Rocky Mountain Laboratories reported in Nature that this age-associated imbalance in HSCs is to blame for a cascade of downstream declines in immune function. And by restoring a youthful balance of these cells with injections of antibodies, they were able to rejuvenate the immune systems of older mice — enabling them to better fend off viral attacks.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Change Healthcare payments predicted restored March 15

knowledge

WSS

Pregnant women don't need prenatal multivitamins, study concludes

RSV shot was 90% effective at preventing hospitalizations in kids

Amylyx ALS drug failure raises questions and concerns

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

RSV shot was 90% effective at preventing hospitalizations in kids

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

explore

comprehensive

Wikipedia

Psychedelics group wrestles with new pharma identity

Microsoft's Peter Lee: Generative AI could help doctors be more human

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

DIEP, the 'gold standard' of breast reconstruction, is under threat

First over

Hepatitis C has a cure — but many Americans still lack access to it

UnitedHealth quietly bought dozens of outpatient centers

Continuity nursing helped my family in our darkest PICU moments

Just how do doctors, lawmakers, and the public define abortion?

hotspot

Sen. Paul opposes bill to ban Chinese biotechs

Amylyx ALS drug failure raises questions and concerns

A deep dive into Applied Therapeutics’ data, and questions on Cassava

IVF, abortion rights issues kick off Biden’s State of the Union

State of the Union pitch: Bigger Medicare drug price negotiations

What it’s like to watch children die of measles

focus

knowledge

hotspot

entertainment